Lari Lehtiö

41PUBLICATIONS
62CO-AUTHORS
Polymerisation mechanismsMedical infection agents (incl. prions)Biomolecular modelling and designNanoelectromechanical systemsF-block chemistry
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (41)

|Oct 05, 2026
Dimerization of human PARP15 is required for NAD+ binding and automodification.

|Sep 09, 2026
Mutations in the macrodomain 1 of nsp3 attenuate PEDV virulence in vivo without impairing in vitro replication.

|Jul 29, 2026
Replacement soaking for human tankyrase 2 enables studies on substrate analogues and inhibitors.

|Jan 24, 2026
Automodification of N-terminal serine residues facilitates PARP2 release from DNA.

Saurabh Singh Dhakar, Albert Galera-Prat, Jin Cai

|Dec 27, 2025
Discovery of Fused Isoquinolinone/Triazole as a Scaffold for Tankyrase and PARP Inhibition.

Konstantinos A Ouzounthanasis, Chiara Bosetti, Juho Alaviuhkola

|Oct 30, 2025
A FRET-Based High-Throughput Screening Assay for the Discovery of Mycobacterium tuberculosis DNA ADP-Ribosylglycohydrolase DarG Inhibitors.

Men Thi Hoai Duong, Yang Lu, Ivan Ahel

Pageof 7

Frequent Collaborators

7 joint publications

Dana V Ferraris

6 joint publications

Anthony R Fehr

6 joint publications

Sven T Sowa

6 joint publications

Mirko M Maksimainen